Stereotactic radiosurgery (SRS) and stereotactic radiotherapy (SRT) is not recommended to be available as a treatment option through routine commissioning for the treatment of the surgical cavity following resection of cerebral metastases (all ages).

Stereotactic ablative radiotherapy (SABR) is not recommended to be available as a treatment option for patients with previously irradiated, locally recurrent para-aortic tumours.

Stereotactic ablative radiotherapy (SABR) is recommended to be available as a treatment option through routine commissioning for the treatment of previously irradiated, locally recurrent primary pelvic tumours within the criteria set out in this document.

Sapropterin is recommended to be available as a treatment option through routine commissioning for phenylketonuria

England’s top children and young people’s mental health doctor is encouraging youngsters to seek help if they need it, as NHS Digital’s new survey shows there has been a rise in mental health problems in children and young people during the pandemic. The survey shows one in six children and young people had a probable […]

Service specifications are important in clearly defining the standards of care expected from organisations funded by NHS England to provide specialised care. The specifications have been developed by specialised clinicians, commissioners, expert patients and public health representatives to describe both core and developmental service standards.

Summary
Uridine triacetate is recommended as a treatment option through routine commissioning for the treatment of patients exhibiting early-onset severe toxicities following 5-fluorouracil or capecitabine administration within the criteria set out in this document.